GO
Loading...

Ataluren drives PTC Therapeutics

Friday, 23 May 2014 | 10:25 AM ET

CNBC's Meg Tirrell reports shares of PTC Therapeutics are surging on a recommendation of the drug "Ataluren" designed to treat Duchenne muscular dystrophy which could be a billion dollar drug.